Last 12 months
Inside the activity.
0 purchase rows · 73 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 42 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 2, 2022 21:56 UTC |
OLIPHANT LAURADirector
|
SaleCommon Stock | 3,474 | $27.01 | $93,831.70 |
DisclosureSEC source: 0001654954-22-016086 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 9,177 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.000 to $27.025, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:56 UTC |
SCOTT GEOFFREY GATESDirector
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-016087 · section16.xml · nonDerivative · entry 1 SCOTT GEOFFREY GATES · CIK 0001824121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,668 F1 · shares: The shares were donated to The Hill School. Read SEC document |
| November 23, 2022 Filed Nov 24, 2022 02:00 UTC |
OLIPHANT LAURADirector
|
SaleCommon Stock | 1,901 | $27.00 | $51,327.00 |
DisclosureSEC source: 0001654954-22-015718 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,651 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 00:35 UTC | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001654954-22-015630 · section16.xml · derivative · entry 2 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,000 shares Expires 2025-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
|
| November 21, 2022 Filed Nov 22, 2022 00:35 UTC | Exercise / conversionCommon Stock | 23,000 | $2.40 | $55,200.00 |
DisclosureSEC source: 0001654954-22-015630 · section16.xml · nonDerivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
|
| November 18, 2022 Filed Nov 23, 2022 00:38 UTC Amendment | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001654954-22-015667 · section16.xml · derivative · entry 2 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,000 shares Expires 2025-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: This report on Form 4/A is being file to correct the transaction date on form 4 originally filed on November 21, 2022. The correct transaction date was November 18, 2022. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
|
| November 18, 2022 Filed Nov 23, 2022 00:38 UTC Amendment | Exercise / conversionCommon Stock | 23,000 | $2.40 | $55,200.00 |
DisclosureSEC source: 0001654954-22-015667 · section16.xml · nonDerivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: This report on Form 4/A is being file to correct the transaction date on form 4 originally filed on November 21, 2022. The correct transaction date was November 18, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
|
| November 15, 2022 Filed Nov 17, 2022 01:54 UTC |
SCOTT GEOFFREY GATESDirector
|
SaleCommon Stock | 15,000 | $25.21 | $378,150.00 |
DisclosureSEC source: 0001654954-22-015470 · section16.xml · nonDerivative · entry 1 SCOTT GEOFFREY GATES · CIK 0001824121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,668 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $25.25, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 00:04 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 69,690 | $25.90 | $1,804,768.90 |
DisclosureSEC source: 0001654954-22-015466 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,051 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $26.66, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted shares and unvested restricted stock units. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:56 UTC |
ROGERS VERNONExec. VP Sales and Marketing
|
SaleCommon Stock | 20,000 | $26.32 | $526,400.00 |
DisclosureSEC source: 0001654954-22-015462 · section16.xml · nonDerivative · entry 1 ROGERS VERNON · CIK 0001756642 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,129 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $26.66, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:01 UTC |
SLAYEN HOWARD TDirector
|
SaleCommon Stock | 6,000 | $25.53 | $153,164.40 |
DisclosureSEC source: 0001654954-22-015433 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,924 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.27 to $25.815, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F4 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 21:01 UTC |
SLAYEN HOWARD TDirector
|
SaleCommon Stock | 22,113 | $25.02 | $553,203.13 |
DisclosureSEC source: 0001654954-22-015433 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,924 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.235, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC |
SLAYEN HOWARD TDirector
|
SaleCommon Stock | 19,887 | $25.01 | $497,379.84 |
DisclosureSEC source: 0001654954-22-015298 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,037 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.06, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC |
OLIPHANT LAURADirector
|
SaleCommon Stock | 6,731 | $25.00 | $168,275.00 |
DisclosureSEC source: 0001654954-22-015297 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,552 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 22:58 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
SaleCommon Stock | 21,910 | $21.00 | $460,110.00 |
DisclosureSEC source: 0001654954-22-014456 · section16.xml · nonDerivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,358 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 20:25 UTC |
OLIPHANT LAURADirector
|
SaleCommon Stock | 1,083 | $22.04 | $23,873.98 |
DisclosureSEC source: 0001654954-22-014237 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 21,283 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.04 to $22.045, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 01:43 UTC |
OLIPHANT LAURADirector
|
SaleCommon Stock | 5,806 | $22.00 | $127,732.00 |
DisclosureSEC source: 0001654954-22-014086 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 22,366 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:01 UTC |
SLAYEN HOWARD TDirector
|
SaleCommon Stock | 18,000 | $20.00 | $360,081.00 |
DisclosureSEC source: 0001654954-22-014023 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,924 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:00 UTC |
DANESH FARIBADirector
|
SaleCommon Stock | 2,325 | $20.00 | $46,500.00 |
DisclosureSEC source: 0001654954-22-014021 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,995 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:13 UTC |
POSEDEL RHEA JDirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013925 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 623,821 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:13 UTC |
POSEDEL RHEA JDirector
|
GrantCommon Stock | 3,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013925 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 618,821 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 00:33 UTC |
ROSATI MARIO MDirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013931 · section16.xml · nonDerivative · entry 2 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 67,358 F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. F2 · ownership.nature: Shares held by Mario M. Rosati and Danelle Storm Rosati, Trustees of the Rosati Family Trust dated May 23, 1997. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 00:33 UTC |
ROSATI MARIO MDirector
|
GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013931 · section16.xml · nonDerivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 62,358 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · ownership.nature: Shares held by Mario M. Rosati and Danelle Storm Rosati, Trustees of the Rosati Family Trust dated May 23, 1997. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:37 UTC |
SCOTT GEOFFREY GATESDirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013929 · section16.xml · nonDerivative · entry 3 SCOTT GEOFFREY GATES · CIK 0001824121 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 70,686 F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:37 UTC |
SCOTT GEOFFREY GATESDirector
|
GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013929 · section16.xml · nonDerivative · entry 2 SCOTT GEOFFREY GATES · CIK 0001824121 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 65,686 F2 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:37 UTC |
SCOTT GEOFFREY GATESDirector
|
GiftCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013929 · section16.xml · nonDerivative · entry 1 SCOTT GEOFFREY GATES · CIK 0001824121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,668 F1 · shares: The shares were donated to The Hill School. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:20 UTC |
DANESH FARIBADirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013927 · section16.xml · nonDerivative · entry 2 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,320 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:20 UTC |
DANESH FARIBADirector
|
GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013927 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,320 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:08 UTC |
OLIPHANT LAURADirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013923 · section16.xml · nonDerivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 28,172 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:08 UTC |
OLIPHANT LAURADirector
|
GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013923 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 23,172 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 22:36 UTC |
SLAYEN HOWARD TDirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013921 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,924 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 22:36 UTC |
SLAYEN HOWARD TDirector
|
GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013921 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,924 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:00 UTC | Tax withholdingCommon Stock | 434 | $18.50 | $8,029.00 |
DisclosureSEC source: 0001654954-22-013903 · section16.xml · nonDerivative · entry 2 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,582 F2 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of performance-based RSUs described in footnote 1. This does not represent a sale by the Reporting Person. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
|
| October 18, 2022 Filed Oct 19, 2022 20:00 UTC | GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013903 · section16.xml · nonDerivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,016 F1 · shares: Represents shares of common stock issued upon vesting of performance-based RSUs. Read SEC document |
|
| October 18, 2022 Filed Oct 19, 2022 20:00 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
SaleCommon Stock | 30,000 | $18.65 | $559,500.00 |
DisclosureSEC source: 0001654954-22-013902 · section16.xml · nonDerivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 127,673 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:00 UTC |
SPORCK ALISTAIR NVP, CONTACTOR BUSINESS UNIT
|
Tax withholdingCommon Stock | 439 | $18.50 | $8,121.50 |
DisclosureSEC source: 0001654954-22-013901 · section16.xml · nonDerivative · entry 1 SPORCK ALISTAIR N · CIK 0001939261 · VP, CONTACTOR BUSINESS UNIT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,561 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 14, 2022 Filed Oct 15, 2022 01:49 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
Tax withholdingCommon Stock | 662 | $14.77 | $9,777.74 |
DisclosureSEC source: 0001654954-22-013783 · section16.xml · nonDerivative · entry 2 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,268 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 14, 2022 Filed Oct 15, 2022 01:32 UTC | Tax withholdingCommon Stock | 385 | $14.77 | $5,686.45 |
DisclosureSEC source: 0001654954-22-013781 · section16.xml · nonDerivative · entry 2 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,766 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
|
| October 13, 2022 Filed Oct 15, 2022 01:49 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
Tax withholdingCommon Stock | 223 | $16.40 | $3,657.20 |
DisclosureSEC source: 0001654954-22-013783 · section16.xml · nonDerivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,930 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| October 13, 2022 Filed Oct 15, 2022 01:32 UTC | Tax withholdingCommon Stock | 105 | $16.40 | $1,722.00 |
DisclosureSEC source: 0001654954-22-013781 · section16.xml · nonDerivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,151 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
|
| October 12, 2022 Filed Oct 13, 2022 20:00 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,700 | $0.00 Strike: $2.17 | $0.00 |
DisclosureSEC source: 0001654954-22-013683 · section16.xml · derivative · entry 5 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,700 shares Expires 2022-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 12, 2022 Filed Oct 13, 2022 20:00 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionCommon Stock | 8,700 | $2.17 | $18,879.00 |
DisclosureSEC source: 0001654954-22-013683 · section16.xml · nonDerivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:01 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionNon-Qualied Stock Option (right to buy) · Derivative | 1,300 | $0.00 Strike: $2.17 | $0.00 |
DisclosureSEC source: 0001654954-22-013586 · section16.xml · derivative · entry 6 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Common Stock · 1,300 shares Expires 2022-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:01 UTC |
ROSATI MARIO MDirector
|
SaleCommon Stock | 1,300 | $16.13 | $20,969.00 |
DisclosureSEC source: 0001654954-22-013586 · section16.xml · nonDerivative · entry 2 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,798 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.31 to $17.48, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:01 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionCommon Stock | 1,300 | $2.17 | $2,821.00 |
DisclosureSEC source: 0001654954-22-013586 · section16.xml · nonDerivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:00 UTC |
DANESH FARIBADirector
|
SaleCommon Stock | 1,550 | $16.12 | $24,986.00 |
DisclosureSEC source: 0001654954-22-013585 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,158 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.31 to $17.39, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:05 UTC |
Erickson GaynDirector · President and CEO
|
OtherCommon Stock | 2,217 | $2.18 | $4,843.04 |
DisclosureSEC source: 0001654954-22-013326 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,741 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:02 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
OtherCommon Stock | 3,000 | $2.18 | $6,553.50 |
DisclosureSEC source: 0001654954-22-013328 · section16.xml · nonDerivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,153 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:02 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
OtherCommon Stock | 3,000 | $2.18 | $6,553.50 |
DisclosureSEC source: 0001654954-22-013327 · section16.xml · nonDerivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 157,673 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:01 UTC | OtherCommon Stock | 2,700 | $2.18 | $5,898.15 |
DisclosureSEC source: 0001654954-22-013325 · section16.xml · nonDerivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,256 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.